International Workshop On Scleroderma Research Corporation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2016 | 0 | 0 | 0 | — | — |
| 2017 | 246,259 | 102,985 | 143,274 | 16.7 | 0% |
| 2018 | 687 | 1,016 | −329 | 1688.3 | 0% |
| 2019 | 95,760 | 117,415 | −21,655 | 12.4 | 5% |
| 2020 | 0 | 13,728 | −13,728 | 94.0 | 9% |
| 2021 | 0 | 1,011 | −1,011 | 1264.7 | 0% |
| 2022 | 344,059 | 389,505 | −45,446 | 1.9 | 6% |
| 2023 | 20,000 | 2,104 | 17,896 | 450.6 | 0% |
In its most recent public year (2023), this organization brought in $17,896 more than it spent. Its reserves stood at about 450.6 months of spending. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
International Workshop On Scleroderma Research Corporation's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works